ASSOCIACAO UNIVERSIDADE EMPRESA PARA DESENVOLVIMENTO TECMINHO

Their core work

TecMinho is a university-enterprise association linked to the University of Minho in Guimarães, Portugal, bridging academic research and industrial application. They specialize in translating nanomedicine and biomedical research into market-ready products, connecting researchers with SMEs and investors. Their work spans nanobiomedical technologies, natural product development for healthcare, and building innovation ecosystems that help scientific discoveries reach clinical and commercial use.

What they specialise in

How they've shifted over time

TecMinho's early H2020 work (2015-2017) centered on building nanomedicine translation ecosystems — connecting SMEs with researchers, creating communication platforms, and facilitating investor engagement through projects like ENATRANS and C2NET. From 2017 onward, their focus shifted toward deeper scientific engagement: coordinating targeted drug delivery research (FOLSMART), contributing to open innovation roadmapping (NOBEL), and most recently moving into ethnobotany and natural products chemistry (EthnoHERBS). The trajectory shows a clear progression from pure ecosystem-building and networking toward hands-on research coordination in biomedical and natural product domains.

TecMinho is evolving from a pure innovation intermediary toward an active research partner in biomedical and natural product sciences, making them increasingly valuable for consortia needing both scientific depth and technology transfer expertise.

How they like to work

TecMinho predominantly participates as a partner (4 of 5 projects) rather than leading consortia, though they successfully coordinated FOLSMART — their largest project by far (EUR 1.13M). With 52 unique partners across 15 countries, they maintain a broad and diverse network rather than relying on repeated partnerships. This profile suggests a well-connected intermediary that brings value through its networks and translation capabilities, comfortable in supporting roles but capable of coordination when the topic aligns with their core nanomedicine expertise.

TecMinho has collaborated with 52 distinct partners across 15 countries, indicating a well-distributed European network built through diverse project types ranging from manufacturing coordination to biomedical research mobility schemes.

What sets them apart

TecMinho occupies a rare niche as a university-enterprise interface organization with deep roots in nanomedicine translation. Unlike pure research labs or standard technology transfer offices, they combine hands-on ecosystem building (investor connections, SME engagement, communication platforms) with genuine scientific project coordination. For consortium builders, they offer a two-in-one package: a Portuguese partner that can handle both the research tasks and the exploitation/dissemination workstreams that many academic partners struggle with.

Highlights from their portfolio

• FOLSMART
  Their only coordinated project and by far the largest (EUR 1.13M), focused on targeted nanodevices for rheumatoid arthritis — demonstrating real scientific leadership beyond ecosystem facilitation.
• EthnoHERBS
  Their most recent project (2019-2025) marks a strategic pivot into ethnobotany and natural products chemistry, a new research direction combining biodiversity with healthcare applications.
• ENATRANS
  Exemplifies their core value proposition — enabling nanomedicine translation by building bridges between researchers, SMEs, investors, and clinics.